Literature DB >> 7677755

Participation of a proton-cotransporter, MCT1, in the intestinal transport of monocarboxylic acids.

I Tamai1, H Takanaga, H Maeda, Y Sai, T Ogihara, H Higashida, A Tsuji.   

Abstract

A molecular mechanism for the intestinal monocarboxylic acid transport was characterized by using a proton/monocarboxylate transporter, MCT1, in Chinese hamster ovary (CHO) cells, first found by Garcia et al. (Cell, 76, 865-873, 1994). Northern blotting analysis showed that MCT1-isomers exist in the rat and rabbit intestinal enterocytes and Caco-2 cells. The expression of [14C]lactic acid uptake by Xenopus laevis oocytes injected with rabbit intestinal mRNA was reduced by hybridizing the mRNA with a MCT1 cDNA of CHO cells before microinjection used as the antisense DNA. [14C]Lactic acid uptake by CHO cells was pH dependent, saturable, stereospecific, and reduced in the presence of acetic acid, benzoic acid, S- and R-ibuprofen, S- and R-mandelic acid, nicotinic acid, pravastatin, propionic acid and valproic acid. In addition, several monocarboxylic acids were transported in pH-dependent and saturable manners. These results suggest that the intestinal MCT1-related protein contributes to a carrier-mediated absorption for organic weak acid compounds.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7677755     DOI: 10.1006/bbrc.1995.2312

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  43 in total

1.  Messenger RNA expression of transporter and ion channel genes in undifferentiated and differentiated Caco-2 cells compared to human intestines.

Authors:  Pascale Anderle; Vera Rakhmanova; Katie Woodford; Noa Zerangue; Wolfgang Sadée
Journal:  Pharm Res       Date:  2003-01       Impact factor: 4.200

2.  Ibuprofen is a non-competitive inhibitor of the peptide transporter hPEPT1 (SLC15A1): possible interactions between hPEPT1 substrates and ibuprofen.

Authors:  Diana Højmark Omkvist; Birger Brodin; Carsten Uhd Nielsen
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

3.  Prophylactic tributyrin treatment mitigates chronic-binge ethanol-induced intestinal barrier and liver injury.

Authors:  Gail A Cresci; Bryan Glueck; Megan R McMullen; Wei Xin; Daniella Allende; Laura E Nagy
Journal:  J Gastroenterol Hepatol       Date:  2017-09       Impact factor: 4.029

4.  Mechanistic modeling of monocarboxylate transporter-mediated toxicokinetic/toxicodynamic interactions between γ-hydroxybutyrate and L-lactate.

Authors:  Bridget L Morse; Nisha Vijay; Marilyn E Morris
Journal:  AAPS J       Date:  2014-05-23       Impact factor: 4.009

Review 5.  Carrier-mediated intestinal transport of drugs.

Authors:  A Tsuji; I Tamai
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

6.  Application of fractal kinetics for carrier-mediated transport of drugs across intestinal epithelial membrane.

Authors:  T Ogihara; I Tamai; A Tsuji
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

7.  Possible role of anion exchanger AE2 as the intestinal monocarboxylic acid/anion antiporter.

Authors:  H Yabuuchi; I Tamai; Y Sai; A Tsuji
Journal:  Pharm Res       Date:  1998-03       Impact factor: 4.200

8.  Identification and characterization of a monocarboxylate transporter (MCT1) in pig and human colon: its potential to transport L-lactate as well as butyrate.

Authors:  A Ritzhaupt; I S Wood; A Ellis; K B Hosie; S P Shirazi-Beechey
Journal:  J Physiol       Date:  1998-12-15       Impact factor: 5.182

9.  Regulation of intracellular pH during H+-coupled oligopeptide absorption in enterocytes from guinea-pig ileum.

Authors:  H Hayashi; Y Suzuki
Journal:  J Physiol       Date:  1998-09-01       Impact factor: 5.182

10.  Salicylic acid transport in Ricinus communis involves a pH-dependent carrier system in addition to diffusion.

Authors:  Françoise Rocher; Jean-François Chollet; Sandrine Legros; Cyril Jousse; Rémi Lemoine; Mireille Faucher; Daniel R Bush; Jean-Louis Bonnemain
Journal:  Plant Physiol       Date:  2009-06-03       Impact factor: 8.340

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.